November 14, 2018
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, expressed concern in October over the price of chimeric antigen receptor (CAR) T-cell therapies. In an interview with STAT News during a session at the Milken Institute’s Future of Health Summit 2018, Dr. Gottlieb warned that the failure to develop CAR T-cell therapy payment structures could slow...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand